Cellular and Molecular Pathogenic Mechanisms of Insulin‐Dependent Diabetes Mellitus
- 1 April 2001
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 928 (1) , 200-211
- https://doi.org/10.1111/j.1749-6632.2001.tb05650.x
Abstract
Insulin‐dependent diabetes mellitus (IDDM), also known as type 1 diabetes, is an organ‐specific autoimmune disease resulting from the destruction of insulin‐producing pancreatic β cells. The hypothesis that IDDM is an autoimmune disease has been considerably strengthened by the study of animal models such as the BioBreeding (BB) rat and the nonobese diabetic (NOD) mouse, both of which spontaneously develop a diabetic syndrome similar to human IDDM. β cell autoantigens, macrophages, dendritic cells, B lymphocytes, and T cells have been shown to be involved in the pathogenesis of autoimmune diabetes. Among the β cell autoantigens identified, glutamic acid decarboxylase (GAD) has been extensively studied and is the best characterized. β cell‐specific suppression of GAD expression in NOD mice results in the prevention of IDDM. Macrophages and/or dendritic cells are the first cell types to infiltrate the pancreatic islets. Macrophages play an essential role in the development and activation of β cell‐cytotoxic T cells. B lymphocytes play a role as antigen‐presenting cells, and T cells have been shown to play a critical role as final effectors that kill β cells. Cytokines secreted by immunocytes, including macrophages and T cells, may regulate the direction of the immune response toward Th1 or Th2 as well as cytotoxic effector cell or suppressor cell dominance. β cells are destroyed by apoptosis through Fas‐Fas ligand and TNF‐TNF receptor interactions and by granzymes and perforin released from cytotoxic effector T cells. Therefore, the activated macrophages and T cells, and cytokines secreted from these immunocytes, act synergistically to destroy β cells, resulting in the development of autoimmune IDDM.Keywords
This publication has 53 references indexed in Scilit:
- Control of Autoimmune Diabetes in NOD Mice by GAD Expression or Suppression in β CellsScience, 1999
- Insulin-dependent diabetes mellitus as a β-cell targeted disease of immunoregulationJournal of Autoimmunity, 1995
- Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD miceEuropean Journal of Immunology, 1995
- Responses of NOD Congenic Mice to a Glutamic Acid Decarboxylase-derived PeptideJournal of Autoimmunity, 1994
- Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic isletsDiabetes, 1993
- Following a diabetogenic T cell from genesis through pathogenesisCell, 1993
- Studies on autoimmunity for T-cell-mediated beta-cell destruction. Distinct difference in beta-cell destruction between CD4+ and CD8+ T-cell clones derived from lymphocytes infiltrating the islets of NOD miceDiabetes, 1992
- Acceleration of Diabetes in Young Nod Mice with a CD4 + Islet-specific T Cell CloneScience, 1990
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells.The Journal of Experimental Medicine, 1987